Industries > Pharma > Animal Vaccine Market Report to 2031
Animal Vaccine Market Report to 2031
By Product (Live Attenuated Vaccine, Conjugate Vaccine, Inactivated Vaccine, Toxoid Vaccine & others), By Vaccine Type, Companion Vaccine (Feline vaccine, Canine vaccine) Livestock vaccine (Equine, Porcine, Poultry & Others) and Leading Regional/ Country market analysis
Animal Vaccines Market– our new study reveals trends, R&D progress, and predicted revenues
Where is the Animal Vaccines market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2031, assessing data, trends, opportunities, and business prospects there.
Discover how to stay ahead
Our Animal Vaccines page report provides tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Animal Vaccines Market. See how to exploit the opportunities.
Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints, and challenges), product profiles and commercial developments.
Animal Vaccines Market, By Product 2021 to 2031
• Live attenuated vaccine
• Conjugate Vaccines
• Inactivated Vaccines
• Toxoid Vaccines
• Others
Animal Vaccines Market, by Vaccine Type 2021 to 2031
• Companion vaccine
o Feline vaccine
o Canine vaccine
• Livestock vaccine
o Equine
o Porcine
o Poultry
o Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:
• North America
o U.S.
o Canada
• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Rest of Asia Pacific
• Latin America
o Brazil
o Mexico
o Rest of Latin America
• Middle East and Africa
The report also includes profiles and for some of the leading companies in the Animal Vaccines Market, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
Overall world revenue for Animal Vaccines Market with forecasts for Product and Vaccine Type, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments.
Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Animal Vaccines Market report helps you
In summary, our 300+ page report provides you with the following knowledge:
• Revenue forecasts to 2031 for Animal Vaccines Market, with forecasts for Product and Vaccine Type, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2031 for 5 regional and 16 key national markets – See forecasts for the Animal Vaccines market in North America, Europe, Asia-Pacific, and Rest of the World. Also forecasted is the market in the US, Canada, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, Rest of Asia Pacific, Latin America and Middle East and Africa among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for Animal Vaccines of the major companies involved in the Animal Vaccines Market. Some of the company’s profiled in this report include-
• Bayer AG
• Elanco Animal Health Inc.
• Merck & Co., Inc.
• Zoetis
• Virbac
• Boehringer Ingelheim
• Sanofi
• BioVet KZ
• Zoetis Inc.
• Bimeda Holdings Plc
• Vaxxinova GmbH-Germany
• Romvac company S.A.
• Hygieia Biological Laboratories
• IDEXX Laboratories, Inc
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the global Animal vaccines Market and leading companies. You will find data, trends, and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Animal Vaccines Market Report to 2031: By Product (Live Attenuated Vaccine, Conjugate Vaccine, Inactivated Vaccine, Toxoid Vaccine & others), By Vaccine Type, Companion Vaccine (Feline vaccine, Canine vaccine) Livestock vaccine (Equine, Porcine, Poultry & Others) and Leading Regional/ Country market analysis. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Global Animal Vaccines Market
2.1. Animal Vaccines Market Definition
2.2. By Product Submarkets Definitions
2.3. By Type Submarkets Definitions
3. Global Animal Vaccines Market Overview
3.1. Global Animal Vaccines Market Size and Forecast by Region
3.2. Global Animal Vaccines Market Share by Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Increasing Ownership & Awareness for Companion Animals.
3.3.1.2. Cost-Effective Method to Prevent Animal Disease
3.3.1.3. Increase in Demand for Animal Health Insurance and Animal Health Expenditure
3.3.1.4. Prevalence and Control of Animal Diseases.
3.3.1.5. Increasing Demand for Safe & Effective Food Production.
3.3.2. Market Restraints/Challenges
3.3.2.1. High Cost of Animal Healthcare Services.
3.3.2.2. Restrictions on the Use of Vaccines in Food Producing Animals
3.3.2.3. Resistance for Vaccines
3.3.3. Opportunities
3.3.3.1. Increasing Need for Food Safety Vaccine
3.3.3.2. Reducing Need for Antibiotics
3.3.3.3. Advancement of Vaccine
3.3.3.4. Government Initiatives for Animal Health & Safety
3.3.4. Global Animal Vaccines Market: Trends
3.3.4.1. Focus on R&D investment
3.3.4.2. Government Initiatives
3.3.4.3. Focus on Investment in Emerging Economies
3.3.5. Porter’s Five Forces Analysis
3.3.5.1. Competitive Rivalry
3.3.5.2. Supplier Power
3.3.5.3. Buyer Power
3.3.5.4. Threat of Substitution
3.3.5.5. Threat of New Entry
4. Global Animal Vaccines Market Analysis and Forecast 2021-2031, by Product (Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Live Attenuated Vaccines
4.1.1.1. Conventional vaccination method drives the market growth.
4.1.2. Conjugate Vaccines
4.1.2.1. Capability to provide strong immune response
4.1.3. Inactivated Vaccines
4.1.3.1. Provides immunity against Hepatitis A Flu, Polio & Rabies
4.1.4. Toxoid Vaccines
4.1.4.1. Provides protection against Diphtheria and Tetanus.
4.1.5. Others
5. Global Animal Vaccines Market Analysis and Forecast, 2021-2031 by Vaccine Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Companion vaccine
5.1.1.1. Feline vaccine
5.1.1.2. Administration of Core Vaccine Such as Feline Calicivirus (FCV) Feline Leukemia Virus
5.1.1.3. Canine Vaccine
5.1.1.4. Rising Demand for Canine Vaccine Such as Canine Distemper Virus (CDV), Canine Parvovirus (CPV) in Developed Economies.
5.1.2. Livestock Vaccine
5.1.2.1. Equine
5.1.2.2. Increasing Demand for Equine Vaccine Such as Equine Influenza, Tetanus, Equine Herpes Virus 1 And 4
5.1.2.3. Porcine
5.1.2.4. Increasing Cases of Porcine Epidemic Diarrhea and Other Swine Diseases
5.1.2.5. Poultry
5.1.2.6. Increasing Consumption of Food Producing Animals Such as Poultry
5.1.2.7. Others
6. North America Animal Vaccines Market Analysis and Forecast, 2021-2031 Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Market Overview
6.2. North America Animal Vaccines Market Size and Forecast by Product
6.2.1. Live attenuated vaccine Submarket Expected to Grow at Fastest Rate
6.3. North America Animal Vaccines Market Size and Forecast by Type
6.3.1. Livestock Animal Submarket to Grow at Fastest Rate
6.4. U.S. Animal Vaccines Market
6.4.1. Increasing animal health expenditure and consumption of livestock.
6.5. Canada Animal Vaccines Market
6.5.1. Increasing adoption of companion animals.
7. Europe Animal Vaccines Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Market Overview
7.2. Europe Animal Vaccines Market Size and Forecast by Product
7.2.1. Live attenuated vaccine Submarket Expected to Grow at Significant Rate
7.3. Europe Animal Vaccines Market Size and Forecast by Type
7.3.1. Livestock vaccine Submarket to Grow at Significant Rate
7.4. UK Animal Vaccines Market
7.4.1. Rising demand for animal vaccines.
7.5. Germany Animal Vaccines Market
7.5.1. Adoption of advance technologies in European market.
7.6. France Animal Vaccines Market
7.6.1. Presence of market players expected to drive market growth.
7.7. Rest of Europe Animal Vaccines Market
8. Asia Pacific Animal Vaccines Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
8.1. Market Overview
8.2. Asia Pacific Animal Vaccines Market Size and Forecast by Product
8.2.1. Live attenuated vaccine Submarket Expected to Grow at Significant Rate
8.3. Asia Pacific Animal Vaccines Market Size and Forecast by Type
8.3.1. Livestock vaccine Submarket to Grow at Significant Rate
8.4. China Animal Vaccines Market
8.4.1. Increasing demand for animal healthcare Products
8.5. India Animal Vaccines Market
8.5.1. Increasing consumption of livestock and food-based Products.
8.6. Japan Animal Vaccines Market
8.6.1. Increasing animal healthcare awareness
8.7. Rest of Asia Pacific Animal Vaccines Market
9. Latin America Animal Vaccines Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. Latin America Animal Vaccines Market Size and Forecast by Product
9.2.1. Live attenuated vaccine Submarket Expected to Grow at Fastest Rate
9.3. Latin America Animal Vaccines Market Size and Forecast by Type
9.3.1. Livestock vaccine Submarket to Grow at Fastest Rate
9.3.2. Brazil Animal Vaccines Market
9.3.2.1. Growth in companion animal population.
9.3.2.2. Popularity of animal assistant therapies.
9.3.3. Mexico Animal Vaccines Market
9.3.3.1. Government initiative to vaccinate dogs boosts the market.
9.3.3.2. Increasing demand for vaccinating companion animals.
9.3.4. Rest of Latin America Animal Vaccines Market
9.3.4.1. Increasing demand to keep companion animals for safety
9.3.4.2. Increasing vaccination rate
10. MEA Animal Vaccines Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. MEA Animal Vaccines Market Size and Forecast by Product
10.2.1. Live attenuated vaccine Submarket Expected to Grow at Significant Rate
10.3. MEA Animal Vaccines Market Size and Forecast by Type
10.3.1. Livestock Submarket to Grow at Fastest Rate
10.4. South Africa Animal Vaccines Market
10.4.1.1. Increasing demand for livestock-based food Product
10.4.1.2. Increasing animal health expenditure
10.5. Rest of MEA Animal Vaccines Market
10.5.1.1. Rising meat Production
10.5.1.2. Increasing animal healthcare awareness
11. Companies in the Animal Vaccines Market
11.1. Bayer AG
11.1.1. Company Snapshot
11.1.2. Company Overview
11.1.3. Financial Performance (2015-2020)
11.1.3.1. Net Revenue
11.1.3.2. Gross Profit
11.1.3.3. Geographical Revenue, 2020
11.1.4. Product Offerings
11.1.5. Recent Initiatives
11.2. Biogenesis Bago SA
11.2.1. Company Snapshot
11.2.2. Company Overview
11.2.3. Financial Performance
11.2.3.1. Net Revenue
11.2.3.2. Gross Profit
11.2.3.3. Geographical Revenue
11.2.4. Product Offerings
11.2.5. Recent Initiatives
11.3. Biomin Holding GmbH
11.3.1. Company Snapshot
11.3.2. Company Overview
11.3.3. Financial Performance
11.3.3.1. Net Revenue
11.3.3.2. Gross Profit
11.3.3.3. Geographical Revenue
11.3.4. Product Offerings
11.3.5. Recent Initiatives
11.4. Bio-Vet
11.4.1. Company Snapshot
11.4.2. Company Overview
11.4.3. Financial Performance
11.4.3.1. Net Revenue
11.4.3.2. Gross Profit
11.4.3.3. Geographical Revenue
11.4.4. Product Offerings
11.4.5. Recent Initiatives
11.5. Ceva Santé Animale
11.5.1. Company Snapshot
11.5.2. Company Overview
11.5.3. Financial Performance
11.5.3.1. Net Revenue
11.5.3.2. Gross Profit
11.5.3.3. Geographical Revenue
11.5.4. Product Offerings
11.5.5. Recent Initiatives
11.6. Boehringer Ingelheim
11.6.1. Company Snapshot
11.6.2. Company Overview
11.6.3. Financial Performance
11.6.3.1. Net Revenue
11.6.3.2. Gross Profit
11.6.3.3. Geographical Revenue
11.6.4. Product Offerings
11.6.5. Recent Initiatives
11.7. Merck & Co., Inc.
11.7.1. Company Snapshot
11.7.2. Company Overview
11.7.3. Financial Performance
11.7.3.1. Net Revenue
11.7.3.2. Gross Profit
11.7.3.3. Geographical Revenue
11.7.4. Product Offerings
11.7.5. Recent Initiatives
11.8. Virbac
11.8.1. Company Snapshot
11.8.2. Company Overview
11.8.3. Financial Performance
11.8.3.1. Net Revenue
11.8.3.2. Gross Profit
11.8.3.3. Geographical Revenue
11.8.4. Product Offerings
11.8.5. Recent Initiatives
11.9. Zoetis
11.9.1. Company Snapshot
11.9.2. Company Overview
11.9.3. Financial Performance
11.9.3.1. Net Revenue
11.9.3.2. Gross Profit
11.9.3.3. Geographical Revenue
11.9.4. Product Offerings
11.9.5. Recent Initiatives
11.10. IDEXX Laboratories, Inc
11.10.1. Company Snapshot
11.10.2. Company Overview
11.10.3. Financial Performance
11.10.3.1. Net Revenue
11.10.3.2. Gross Profit
11.10.3.3. Geographical Revenue
11.10.4. Product Offerings
11.10.5. Recent Initiatives
11.11. Other Notable Players
12. Conclusion
13. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1. Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 2. Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 3. Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 4. Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 5. Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 6. Animal Vaccines Market Drivers & Restraints 2021
Table 7. Animal Vaccines Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8. Animal Vaccines Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9. Animal Vaccines Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10. Animal Vaccines Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11. Animal Vaccines Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12. Live attenuated Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 13. Conjugate Vaccines Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 14. Conjugate Vaccines Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 15. Conjugate Vaccines Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 16. Conjugate Vaccines Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 17. Inactivated Vaccines Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 18. Inactivated Vaccines Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 19. Inactivated Vaccines Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 20. Inactivated Vaccines Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 21. Inactivated Vaccines Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 22. Toxoid Vaccines Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 23. Toxoid Vaccines Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 24. Toxoid Vaccines Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 25. Toxoid Vaccines Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 26. Toxoid Vaccines Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 27. Other Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 28. Other Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 29. Other Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 30. Other Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 31. Other Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 32. Animal Vaccines Submarket Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 33. Animal Vaccines Submarket Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 34. Animal Vaccines Submarket Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 35. Animal Vaccines Submarket Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 36. Animal Vaccines Submarket Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 37. Companion vaccine Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 38. Companion vaccine Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 39. Companion vaccine Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 40. Companion vaccine Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 41. Companion animal Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 42. Feline vaccine Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 43. Feline vaccine Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 44. Feline vaccine Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 45. Feline vaccine Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 46. Feline vaccine Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 47. Canine vaccine submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 48. Canine vaccine submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 49. Canine vaccine submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 50. Canine vaccine submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 51. Canine vaccine submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 52. Livestock vaccine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 53. Livestock vaccine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 54. Livestock vaccine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 55. Livestock vaccine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 56. Livestock vaccine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 57. Equine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 58. Equine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 59. Equine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 60 Equine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 61. Equine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 62. Porcine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 63. Porcine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 64. Porcine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 65 Porcine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 66. Porcine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 67. Poultry Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 68. Poultry Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 69. Poultry Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 70. Poultry Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 71. Poultry Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 72. Others Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 73. Others Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 74. Others Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 75. Others Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 76. Others Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 77. Regional Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 78. Regional Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 79. Regional Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 80. Regional Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 81. Regional Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 82. North America Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 83. North America Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 84. North America Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 85. North America Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 86. North America Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 87. North America Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 88. North America Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 89. North America Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 90. North America Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 91. North America Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 92. North America Animal Vaccines Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 93. North America Animal Vaccines Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 94. North America Animal Vaccines Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 95. North America Animal Vaccines Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 96. North America Animal Vaccines Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 97. US Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 98. US Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 99. US Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 100. US Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 101. US Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 102. Canada Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 103. Canada Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 104. Canada Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 105. Canada Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 106. Canada Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 107. Europe Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 108. Europe Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 109. Europe Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 110. Europe Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 111. Europe Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 112. Europe Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 113. Europe Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 114. Europe Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 115. Europe Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 116. Europe Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 117. Europe Animal Vaccines Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 118. Europe Animal Vaccines Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 119. Europe Animal Vaccines Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 120. Europe Animal Vaccines Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 121. Europe Animal Vaccines Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 122. UK Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 123. UK Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 124. UK Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 125. UK Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 126. UK Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 127. Germany Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 128. Germany Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 129. Germany Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 130. Germany Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 131. Germany Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 132. France Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 133. France Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 134. France Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 135. France Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 136. France Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 137. Rest of Europe Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 138. Rest of Europe Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 139. Rest of Europe Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 140. Rest of Europe Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 141. Rest of Europe Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 142. Asia Pacific Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 143. Asia Pacific Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 144. Asia Pacific Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 145. Asia Pacific Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 146. Asia Pacific Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 147. Asia Pacific Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 148. Asia Pacific Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 149. Asia Pacific Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 150. Asia Pacific Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 151. Asia Pacific Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 152. Asia Pacific Animal Vaccines Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 153. Asia Pacific Animal Vaccines Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 154. Asia Pacific Animal Vaccines Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 155. Asia Pacific Animal Vaccines Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 156. Asia Pacific Animal Vaccines Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 157. China Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 158. China Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 159. China Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 160. China Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 161. China Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 162. India Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 163. India Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 164. India Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 165. India Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 166. India Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 167. Japan Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 168. Japan Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 169. Japan Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 170. Japan Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 171. Japan Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 172. RoAPAC Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 173. RoAPAC Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 174. RoAPAC Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 175. RoAPAC Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 176. RoAPAC Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 177. Middle East & Africa Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 178. Middle East & Africa Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 179. Middle East & Africa Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 180. Middle East & Africa Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 181. Middle East & Africa Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 182. Middle East & Africa Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 183. Middle East & Africa Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 184. Middle East & Africa Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 185. Middle East & Africa Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 186. Middle East& Africa Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 187. Latin America Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 188. Latin America Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 189. Latin America Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 190. Latin America Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 191. Latin America Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 192. Latin America Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 193. Latin America Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 194. Latin America Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 195. Latin America Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 196. Latin America Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 197. Brazil Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 198. Brazil Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 199. Brazil Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 200. Brazil Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 201. Brazil Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 202. Mexico Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 203. Mexico Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 204. Mexico Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 205. Mexico Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 206. Mexico Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 207. Rest of Latin America Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 208. Rest of Latin America Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 209. Rest of Latin America Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 210. Rest of Latin America Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 211. Rest of Latin America Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 212. Leading 10 Animal Vaccines Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 213. Bayer AG Profile 2020 (CEO, HQ, Founded, Website)
Table 214. Bayer AG Animal Vaccines Selected Recent Contracts 2020 (Date, Program Type, Details)
Table 215. Bayer AG Animal Vaccines Product Offering (Segment, Product Offerings)
Table 216. Biogenesis Bago SA Profile 2020 (CEO, HQ, Founded, Website)
Table 217. Biogenesis Bago SA Animal Vaccines Product Offering (Segment, Product Offerings)
Table 218. Biomin Holding GmbH Profile 2020 (CEO, HQ, Founded, Website)
Table 219. Biomin Holding GmbH Animal Vaccines Selected Recent Contracts 2017-2020 (Date, Program Type, Details)
Table 220. Biomin Holding GmbH Animal Vaccines Product Offering (Segment, Product Offerings)
Table 221. Bio-Vet Profile 2020 (CEO, HQ, Founded, Website)
Table 222. Bio-Vet Selected Recent Contracts 2015-2020 (Date, Program Type, Details)
Table 223. Bio-Vet Animal Vaccines Product Offering (Segment, Product Offerings)
Table 224. Ceva Santé Animale Profile 2020 (CEO, HQ, Founded, Website)
Table 225. Ceva Santé Animale Animal Vaccines Product Offering (Segment, Product Offerings)
Table 226. Boehringer Ingelheim Profile 2020 (CEO, HQ, Founded, Website)
Table 227. Boehringer Ingelheim Animal Vaccines Selected Recent Contracts 2015-2020 (Date, Program Type, Details)
Table 228. Boehringer Ingelheim Animal Vaccines Product Offering (Segment, Product Offerings)
Table 229. Merck & Co., Inc. Profile 2020 (CEO, HQ, Founded, Website)
Table 230. Merck & Co., Inc. Animal Vaccines Product Offering (Segment, Product Offerings)
Table 231. Virbac Profile 2020 (CEO, HQ, Founded, Website)
Table 232. Virbac Animal Vaccines Product Offering (Segment, Product Offerings)
Table 233. Zoetis Profile 2020 (CEO, HQ, Founded, Website)
Table 234. Zoetis Animal Vaccines Product Offering (Segment, Product Offerings)
Table 235. Bimeda Holdings PLC Profile 2020 (CEO, Total Company Sales US$M, HQ, Founded, No. of Employees, Ticker, Website)
Table 236. Bimeda Holdings PLC Total Company Sales 2015-2019 (US$M, AGR %)
Table 237. Bimeda Holdings PLC Product Offering (Segment, Product Offerings)
Table 238. Other Companies Involved in the Animal Vaccines Market (Company, Location)
LIST OF FIGURES
Figure 1. Animal Vaccines Market Overview
Figure 2. Animal Vaccines Market Product Overview
Figure 3. Animal Vaccines Market Type Overview
Figure 4. Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 5. Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 6. Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 7. Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 8. Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 9. Animal Vaccines Submarket Forecast By Product 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 10. Animal Vaccines Submarket Forecast By Product 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 11. Animal Vaccines Submarket Forecast By Product 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 12. Animal Vaccines Submarket Forecast By Product 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 13. Animal Vaccines Submarket Forecast By Product 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 14. Live attenuated vaccine Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 15. Live attenuated vaccine Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID – Scenario V)
Figure 16. Live attenuated vaccine Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 17. Live attenuated vaccine Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 18. Live attenuated vaccine Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 19. Livestock vaccine Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 20. Livestock vaccine Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID – Scenario V)
Figure 21. Livestock vaccine Submarket Forecast 2021-2031(US$M, Global AGR %) (COVID – Scenario U)
Figure 22. Livestock vaccine Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 23. Livestock vaccine Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 24. Regional Animal Vaccines Market Forecast 2021-2031 (Sales US$M, Global AGR %)
Figure 25. Regional Animal Vaccines Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario V)
Figure 26. Regional Animal Vaccines Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario U)
Figure 27. Regional Animal Vaccines Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario W)
Figure 28. Regional Animal Vaccines Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario L)
Figure 29. North America Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %) (Before COVID)
Figure 30. North America Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 31. North America Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 32. North America Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 33. North America Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 34. North America Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %)
Figure 35. North America Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 36. North America Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 37. North America Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 38. North America Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 39. North America Animal Vaccines Market Forecast by Country 2021-2031 (US$M, AGR %) (Before COVID)
Figure 40. North America Animal Vaccines Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 41. North America Animal Vaccines Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 42. North America Animal Vaccines Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 43. North America Animal Vaccines Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 44. US Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 45. US Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 46. US Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 47. US Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 48. US Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 49. Canada Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %)
Figure 50. Canada Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 51. Canada Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 52. Canada Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 53. Canada Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 54. Europe Animal Vaccines Market Forecast by Product 2021-2031 (US$M)
Figure 55. Europe Animal Vaccines Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario V)
Figure 56. Europe Animal Vaccines Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario U)
Figure 57. Europe Animal Vaccines Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario W)
Figure 58. Europe Animal Vaccines Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario L)
Figure 59. Europe Animal Vaccines Market Forecast by Type 2021-2031 (US$M) (Before COVID)
Figure 60. Europe Animal Vaccines Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 61. Europe Animal Vaccines Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 62. Europe Animal Vaccines Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 63. Europe Animal Vaccines Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 64. Europe Animal Vaccines Market Forecast by Country 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 65. Europe Animal Vaccines Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 66. Europe Animal Vaccines Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 67. Europe Animal Vaccines Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 68. Europe Animal Vaccines Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 69. UK Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 70. UK Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 71. UK Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID – Scenario U)
Figure 72. UK Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 73. UK Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 74. Germany Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %)
Figure 75. Germany Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 76. Germany Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 77. Germany Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 78. Germany Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 79. France Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %)
Figure 80. France Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 81. France Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 82. France Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 83. France Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 84. Rest of Europe Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 85. Rest of Europe Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 86. Rest of Europe Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 87. Rest of Europe Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 88. Rest of Europe Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 89. Asia-Pacific Animal Vaccines Market Forecast by Product 2021-2031 (US$M) (Before COVID)
Figure 90. Asia-Pacific Animal Vaccines Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario V)
Figure 91. Asia-Pacific Animal Vaccines Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario U)
Figure 92. Asia-Pacific Animal Vaccines Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario W)
Figure 93. Asia-Pacific Animal Vaccines Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario L)
Figure 94. Asia-Pacific Animal Vaccines Market Forecast by Type 2021-2031 (US$M)
Figure 95. Asia-Pacific Animal Vaccines Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 96. Asia-Pacific Animal Vaccines Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 97. Asia-Pacific Animal Vaccines Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 98. Asia-Pacific Animal Vaccines Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 99. Asia-Pacific Animal Vaccines Market Forecast by Country 2021-2031 (US$M, AGR %) (Before COVID)
Figure 100. Asia-Pacific Animal Vaccines Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 101. Asia-Pacific Animal Vaccines Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 102. Asia-Pacific Animal Vaccines Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 103. Asia-Pacific Animal Vaccines Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 105. China Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %)
Figure 106. China Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 107. China Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 108 China Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 109. China Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 110. India Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %)
Figure 111. India Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 112. India Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 113. India Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 114. India Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 115. Japan Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 116. Japan Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 117. Japan Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 118. Japan Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 119. Japan Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 120. Rest of APAC Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 121. Rest of APAC Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 122. Rest of APAC Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 123. Rest of APAC Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 124. Rest of APAC Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 125. Middle East & Africa Animal Vaccines Market Forecast by Product 2021-2031 (US$M)
Figure 126. Middle East & Africa Animal Vaccines Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario V)
Figure 127. Middle East & Africa Animal Vaccines Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario U)
Figure 128. Middle East & Africa Animal Vaccines Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario W)
Figure 129. Middle East & Africa Animal Vaccines Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario L)
Figure 130. Middle East & Africa Animal Vaccines Market Forecast by Type 2021-2031 (US$M)
Figure 131. Middle East & Africa Animal Vaccines Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 132. Middle East & Africa Animal Vaccines Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 133. Middle East & Africa Animal Vaccines Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 134. Middle East & Africa Animal Vaccines Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 135. Latin America Animal Vaccines Market Forecast by Product 2021-2031 (US$M)
Figure 136. Latin America Animal Vaccines Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario V)
Figure 137. Latin America Animal Vaccines Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario U)
Figure 138. Latin America Animal Vaccines Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario W)
Figure 139. Latin America Animal Vaccines Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario L)
Figure 140. Latin America Animal Vaccines Market Forecast by Type 2021-2031 (US$M)
Figure 141. Latin America Animal Vaccines Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 142. Latin America Animal Vaccines Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 143. Latin America Animal Vaccines Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 144. Latin America Animal Vaccines Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 145. Brazil Animal Vaccines Market Forecast 2021-2031 (US$M)
Figure 146. Brazil Animal Vaccines Market Forecast 2021-2031 (US$M) (COVID - Scenario V)
Figure 147. Brazil Animal Vaccines Market Forecast 2021-2031 (US$M) (COVID - Scenario U)
Figure 148. Brazil Animal Vaccines Market Forecast 2021-2031 (COVID - Scenario W)
Figure 149. Brazil Animal Vaccines Market Forecast 2021-2031 (COVID - Scenario L)
Figure 150. Mexico Animal Vaccines Market Forecast 2021-2031 (US$M) (Before COVID)
Figure 151. Mexico Animal Vaccines Market Forecast 2021-2031 (US$M) (COVID - Scenario V)
Figure 152. Mexico Animal Vaccines Market Forecast 2021-2031 (US$M) (COVID - Scenario U)
Figure 153. Mexico Animal Vaccines Market Forecast 2021-2031 (US$M) (COVID - Scenario W)
Figure 154. Mexico Animal Vaccines Market Forecast 2021-2031 (US$M) (COVID - Scenario L)
Figure 155. Rest of Latin America Animal Vaccines Market Forecast 2021-2031 (US$M) (Before COVID)
Figure 156. Rest of Latin America Animal Vaccines Market Forecast 2021-2031 (US$M) (COVID - Scenario V)
Figure 157. Rest of Latin America Animal Vaccines Market Forecast 2021-2031 (US$M) (COVID - Scenario U)
Figure 158. Rest of Latin America Animal Vaccines Market Forecast 2021-2031 (US$M) (COVID - Scenario W)
Figure 159. Rest of Latin America Animal Vaccines Market Forecast 2021-2031 (US$M) (COVID - Scenario L)
Figure 160. Porter’s Five Force Analysis
Companies Mentioned
1. Bayer AG
2. Heska Corporation
3. Merck Animal Health
4. Boehringer Ingelheim GmbH
5. Sanofi
6. BioVet KZ
7. Zoetis Inc.,
8. Bimeda Holdings Plc
9. Vaxxinova GmbH-Germany
10. Romvac company S.A.
11. Hygieia Biological Laboratories
12. IDEXX Laboratories, Inc
13. Veterinary Diagnostic Technology, Inc.
14. Veterinary Allergy Reference Laboratory
15. Vetazyme Corporation
16. The Vaccine Company
17. T-Cyte Therapeutics, Inc.
18. Pfizer Animal Health
19. Indian Immunologicals Ltd
20. Novartis Vaccines & Diagnostics, Inc.
21. Lohmann Animal Health International
22. GE Healthcare
23. Charles River Laboratories, Inc.
24. MSD Animal Health
25. Bovicure Pharma Private Limited
26. Bupo Animal Health (SA)
27. Chr. Hansen Holdings A/S
28. Danisco A/S DuPont
29. Dechra Pharmaceuticals Plc
30. ECO animal health
31. Animal Medics
32. Ashish Life Science Pvt Limited (ALS)
33. Hatvet Pharma Private Limited
34. Lillidale Animal Health
35. Lutim Pharma Pvt. Ltd.
36. Arab Pesticides and Veterinary Drugs Mfg. Co (Mobedco)
37. Neogen Corporation
38. Norbrook Laboratories Limited
39. Novus International Inc.
40. Orion Corporation
41. PetIQ, LLC
42. Phibro Animal Health
43. SmartVet Holdings Inc.
44. The Alltech Group
45. UCBVET
46. Vetoquinol S.A.
47. Vitafor NV
48. Zydus animal health Limited
49. Abbott Laboratories
50. Bioniche Animal Health, Inc.
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Global Animal Vaccines Market
2.1. Animal Vaccines Market Definition
2.2. By Product Submarkets Definitions
2.3. By Type Submarkets Definitions
3. Global Animal Vaccines Market Overview
3.1. Global Animal Vaccines Market Size and Forecast by Region
3.2. Global Animal Vaccines Market Share by Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Increasing Ownership & Awareness for Companion Animals.
3.3.1.2. Cost-Effective Method to Prevent Animal Disease
3.3.1.3. Increase in Demand for Animal Health Insurance and Animal Health Expenditure
3.3.1.4. Prevalence and Control of Animal Diseases.
3.3.1.5. Increasing Demand for Safe & Effective Food Production.
3.3.2. Market Restraints/Challenges
3.3.2.1. High Cost of Animal Healthcare Services.
3.3.2.2. Restrictions on the Use of Vaccines in Food Producing Animals
3.3.2.3. Resistance for Vaccines
3.3.3. Opportunities
3.3.3.1. Increasing Need for Food Safety Vaccine
3.3.3.2. Reducing Need for Antibiotics
3.3.3.3. Advancement of Vaccine
3.3.3.4. Government Initiatives for Animal Health & Safety
3.3.4. Global Animal Vaccines Market: Trends
3.3.4.1. Focus on R&D investment
3.3.4.2. Government Initiatives
3.3.4.3. Focus on Investment in Emerging Economies
3.3.5. Porter’s Five Forces Analysis
3.3.5.1. Competitive Rivalry
3.3.5.2. Supplier Power
3.3.5.3. Buyer Power
3.3.5.4. Threat of Substitution
3.3.5.5. Threat of New Entry
4. Global Animal Vaccines Market Analysis and Forecast 2021-2031, by Product (Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Live Attenuated Vaccines
4.1.1.1. Conventional vaccination method drives the market growth.
4.1.2. Conjugate Vaccines
4.1.2.1. Capability to provide strong immune response
4.1.3. Inactivated Vaccines
4.1.3.1. Provides immunity against Hepatitis A Flu, Polio & Rabies
4.1.4. Toxoid Vaccines
4.1.4.1. Provides protection against Diphtheria and Tetanus.
4.1.5. Others
5. Global Animal Vaccines Market Analysis and Forecast, 2021-2031 by Vaccine Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Companion vaccine
5.1.1.1. Feline vaccine
5.1.1.2. Administration of Core Vaccine Such as Feline Calicivirus (FCV) Feline Leukemia Virus
5.1.1.3. Canine Vaccine
5.1.1.4. Rising Demand for Canine Vaccine Such as Canine Distemper Virus (CDV), Canine Parvovirus (CPV) in Developed Economies.
5.1.2. Livestock Vaccine
5.1.2.1. Equine
5.1.2.2. Increasing Demand for Equine Vaccine Such as Equine Influenza, Tetanus, Equine Herpes Virus 1 And 4
5.1.2.3. Porcine
5.1.2.4. Increasing Cases of Porcine Epidemic Diarrhea and Other Swine Diseases
5.1.2.5. Poultry
5.1.2.6. Increasing Consumption of Food Producing Animals Such as Poultry
5.1.2.7. Others
6. North America Animal Vaccines Market Analysis and Forecast, 2021-2031 Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Market Overview
6.2. North America Animal Vaccines Market Size and Forecast by Product
6.2.1. Live attenuated vaccine Submarket Expected to Grow at Fastest Rate
6.3. North America Animal Vaccines Market Size and Forecast by Type
6.3.1. Livestock Animal Submarket to Grow at Fastest Rate
6.4. U.S. Animal Vaccines Market
6.4.1. Increasing animal health expenditure and consumption of livestock.
6.5. Canada Animal Vaccines Market
6.5.1. Increasing adoption of companion animals.
7. Europe Animal Vaccines Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Market Overview
7.2. Europe Animal Vaccines Market Size and Forecast by Product
7.2.1. Live attenuated vaccine Submarket Expected to Grow at Significant Rate
7.3. Europe Animal Vaccines Market Size and Forecast by Type
7.3.1. Livestock vaccine Submarket to Grow at Significant Rate
7.4. UK Animal Vaccines Market
7.4.1. Rising demand for animal vaccines.
7.5. Germany Animal Vaccines Market
7.5.1. Adoption of advance technologies in European market.
7.6. France Animal Vaccines Market
7.6.1. Presence of market players expected to drive market growth.
7.7. Rest of Europe Animal Vaccines Market
8. Asia Pacific Animal Vaccines Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
8.1. Market Overview
8.2. Asia Pacific Animal Vaccines Market Size and Forecast by Product
8.2.1. Live attenuated vaccine Submarket Expected to Grow at Significant Rate
8.3. Asia Pacific Animal Vaccines Market Size and Forecast by Type
8.3.1. Livestock vaccine Submarket to Grow at Significant Rate
8.4. China Animal Vaccines Market
8.4.1. Increasing demand for animal healthcare Products
8.5. India Animal Vaccines Market
8.5.1. Increasing consumption of livestock and food-based Products.
8.6. Japan Animal Vaccines Market
8.6.1. Increasing animal healthcare awareness
8.7. Rest of Asia Pacific Animal Vaccines Market
9. Latin America Animal Vaccines Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. Latin America Animal Vaccines Market Size and Forecast by Product
9.2.1. Live attenuated vaccine Submarket Expected to Grow at Fastest Rate
9.3. Latin America Animal Vaccines Market Size and Forecast by Type
9.3.1. Livestock vaccine Submarket to Grow at Fastest Rate
9.3.2. Brazil Animal Vaccines Market
9.3.2.1. Growth in companion animal population.
9.3.2.2. Popularity of animal assistant therapies.
9.3.3. Mexico Animal Vaccines Market
9.3.3.1. Government initiative to vaccinate dogs boosts the market.
9.3.3.2. Increasing demand for vaccinating companion animals.
9.3.4. Rest of Latin America Animal Vaccines Market
9.3.4.1. Increasing demand to keep companion animals for safety
9.3.4.2. Increasing vaccination rate
10. MEA Animal Vaccines Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. MEA Animal Vaccines Market Size and Forecast by Product
10.2.1. Live attenuated vaccine Submarket Expected to Grow at Significant Rate
10.3. MEA Animal Vaccines Market Size and Forecast by Type
10.3.1. Livestock Submarket to Grow at Fastest Rate
10.4. South Africa Animal Vaccines Market
10.4.1.1. Increasing demand for livestock-based food Product
10.4.1.2. Increasing animal health expenditure
10.5. Rest of MEA Animal Vaccines Market
10.5.1.1. Rising meat Production
10.5.1.2. Increasing animal healthcare awareness
11. Companies in the Animal Vaccines Market
11.1. Bayer AG
11.1.1. Company Snapshot
11.1.2. Company Overview
11.1.3. Financial Performance (2015-2020)
11.1.3.1. Net Revenue
11.1.3.2. Gross Profit
11.1.3.3. Geographical Revenue, 2020
11.1.4. Product Offerings
11.1.5. Recent Initiatives
11.2. Biogenesis Bago SA
11.2.1. Company Snapshot
11.2.2. Company Overview
11.2.3. Financial Performance
11.2.3.1. Net Revenue
11.2.3.2. Gross Profit
11.2.3.3. Geographical Revenue
11.2.4. Product Offerings
11.2.5. Recent Initiatives
11.3. Biomin Holding GmbH
11.3.1. Company Snapshot
11.3.2. Company Overview
11.3.3. Financial Performance
11.3.3.1. Net Revenue
11.3.3.2. Gross Profit
11.3.3.3. Geographical Revenue
11.3.4. Product Offerings
11.3.5. Recent Initiatives
11.4. Bio-Vet
11.4.1. Company Snapshot
11.4.2. Company Overview
11.4.3. Financial Performance
11.4.3.1. Net Revenue
11.4.3.2. Gross Profit
11.4.3.3. Geographical Revenue
11.4.4. Product Offerings
11.4.5. Recent Initiatives
11.5. Ceva Santé Animale
11.5.1. Company Snapshot
11.5.2. Company Overview
11.5.3. Financial Performance
11.5.3.1. Net Revenue
11.5.3.2. Gross Profit
11.5.3.3. Geographical Revenue
11.5.4. Product Offerings
11.5.5. Recent Initiatives
11.6. Boehringer Ingelheim
11.6.1. Company Snapshot
11.6.2. Company Overview
11.6.3. Financial Performance
11.6.3.1. Net Revenue
11.6.3.2. Gross Profit
11.6.3.3. Geographical Revenue
11.6.4. Product Offerings
11.6.5. Recent Initiatives
11.7. Merck & Co., Inc.
11.7.1. Company Snapshot
11.7.2. Company Overview
11.7.3. Financial Performance
11.7.3.1. Net Revenue
11.7.3.2. Gross Profit
11.7.3.3. Geographical Revenue
11.7.4. Product Offerings
11.7.5. Recent Initiatives
11.8. Virbac
11.8.1. Company Snapshot
11.8.2. Company Overview
11.8.3. Financial Performance
11.8.3.1. Net Revenue
11.8.3.2. Gross Profit
11.8.3.3. Geographical Revenue
11.8.4. Product Offerings
11.8.5. Recent Initiatives
11.9. Zoetis
11.9.1. Company Snapshot
11.9.2. Company Overview
11.9.3. Financial Performance
11.9.3.1. Net Revenue
11.9.3.2. Gross Profit
11.9.3.3. Geographical Revenue
11.9.4. Product Offerings
11.9.5. Recent Initiatives
11.10. IDEXX Laboratories, Inc
11.10.1. Company Snapshot
11.10.2. Company Overview
11.10.3. Financial Performance
11.10.3.1. Net Revenue
11.10.3.2. Gross Profit
11.10.3.3. Geographical Revenue
11.10.4. Product Offerings
11.10.5. Recent Initiatives
11.11. Other Notable Players
12. Conclusion
13. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1. Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 2. Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 3. Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 4. Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 5. Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 6. Animal Vaccines Market Drivers & Restraints 2021
Table 7. Animal Vaccines Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8. Animal Vaccines Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9. Animal Vaccines Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10. Animal Vaccines Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11. Animal Vaccines Submarket Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12. Live attenuated Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 13. Conjugate Vaccines Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 14. Conjugate Vaccines Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 15. Conjugate Vaccines Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 16. Conjugate Vaccines Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 17. Inactivated Vaccines Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 18. Inactivated Vaccines Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 19. Inactivated Vaccines Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 20. Inactivated Vaccines Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 21. Inactivated Vaccines Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 22. Toxoid Vaccines Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 23. Toxoid Vaccines Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 24. Toxoid Vaccines Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 25. Toxoid Vaccines Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 26. Toxoid Vaccines Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 27. Other Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 28. Other Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 29. Other Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 30. Other Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 31. Other Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 32. Animal Vaccines Submarket Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 33. Animal Vaccines Submarket Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 34. Animal Vaccines Submarket Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 35. Animal Vaccines Submarket Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 36. Animal Vaccines Submarket Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 37. Companion vaccine Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 38. Companion vaccine Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 39. Companion vaccine Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 40. Companion vaccine Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 41. Companion animal Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 42. Feline vaccine Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 43. Feline vaccine Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 44. Feline vaccine Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 45. Feline vaccine Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 46. Feline vaccine Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 47. Canine vaccine submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 48. Canine vaccine submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 49. Canine vaccine submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 50. Canine vaccine submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 51. Canine vaccine submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 52. Livestock vaccine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 53. Livestock vaccine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 54. Livestock vaccine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 55. Livestock vaccine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 56. Livestock vaccine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 57. Equine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 58. Equine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 59. Equine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 60 Equine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 61. Equine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 62. Porcine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 63. Porcine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 64. Porcine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 65 Porcine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 66. Porcine Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 67. Poultry Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 68. Poultry Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 69. Poultry Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 70. Poultry Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 71. Poultry Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 72. Others Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 73. Others Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 74. Others Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 75. Others Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 76. Others Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 77. Regional Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 78. Regional Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 79. Regional Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 80. Regional Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 81. Regional Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 82. North America Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 83. North America Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 84. North America Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 85. North America Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 86. North America Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 87. North America Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 88. North America Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 89. North America Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 90. North America Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 91. North America Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 92. North America Animal Vaccines Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 93. North America Animal Vaccines Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 94. North America Animal Vaccines Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 95. North America Animal Vaccines Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 96. North America Animal Vaccines Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 97. US Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 98. US Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 99. US Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 100. US Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 101. US Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 102. Canada Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 103. Canada Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 104. Canada Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 105. Canada Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 106. Canada Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 107. Europe Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 108. Europe Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 109. Europe Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 110. Europe Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 111. Europe Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 112. Europe Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 113. Europe Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 114. Europe Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 115. Europe Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 116. Europe Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 117. Europe Animal Vaccines Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 118. Europe Animal Vaccines Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 119. Europe Animal Vaccines Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 120. Europe Animal Vaccines Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 121. Europe Animal Vaccines Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 122. UK Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 123. UK Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 124. UK Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 125. UK Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 126. UK Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 127. Germany Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 128. Germany Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 129. Germany Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 130. Germany Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 131. Germany Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 132. France Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 133. France Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 134. France Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 135. France Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 136. France Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 137. Rest of Europe Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 138. Rest of Europe Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 139. Rest of Europe Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 140. Rest of Europe Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 141. Rest of Europe Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 142. Asia Pacific Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 143. Asia Pacific Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 144. Asia Pacific Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 145. Asia Pacific Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 146. Asia Pacific Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 147. Asia Pacific Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 148. Asia Pacific Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 149. Asia Pacific Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 150. Asia Pacific Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 151. Asia Pacific Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 152. Asia Pacific Animal Vaccines Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 153. Asia Pacific Animal Vaccines Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 154. Asia Pacific Animal Vaccines Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 155. Asia Pacific Animal Vaccines Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 156. Asia Pacific Animal Vaccines Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 157. China Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 158. China Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 159. China Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 160. China Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 161. China Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 162. India Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 163. India Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 164. India Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 165. India Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 166. India Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 167. Japan Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 168. Japan Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 169. Japan Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 170. Japan Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 171. Japan Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 172. RoAPAC Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 173. RoAPAC Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 174. RoAPAC Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 175. RoAPAC Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 176. RoAPAC Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 177. Middle East & Africa Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 178. Middle East & Africa Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 179. Middle East & Africa Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 180. Middle East & Africa Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 181. Middle East & Africa Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 182. Middle East & Africa Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 183. Middle East & Africa Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 184. Middle East & Africa Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 185. Middle East & Africa Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 186. Middle East& Africa Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 187. Latin America Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 188. Latin America Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 189. Latin America Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 190. Latin America Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 191. Latin America Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 192. Latin America Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 193. Latin America Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 194. Latin America Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 195. Latin America Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 196. Latin America Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 197. Brazil Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 198. Brazil Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 199. Brazil Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 200. Brazil Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 201. Brazil Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 202. Mexico Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 203. Mexico Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 204. Mexico Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 205. Mexico Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 206. Mexico Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 207. Rest of Latin America Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 208. Rest of Latin America Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 209. Rest of Latin America Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 210. Rest of Latin America Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 211. Rest of Latin America Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 212. Leading 10 Animal Vaccines Companies (Ranking, Company, Latest Total Company Sales US$M*, HQ)
Table 213. Bayer AG Profile 2020 (CEO, HQ, Founded, Website)
Table 214. Bayer AG Animal Vaccines Selected Recent Contracts 2020 (Date, Program Type, Details)
Table 215. Bayer AG Animal Vaccines Product Offering (Segment, Product Offerings)
Table 216. Biogenesis Bago SA Profile 2020 (CEO, HQ, Founded, Website)
Table 217. Biogenesis Bago SA Animal Vaccines Product Offering (Segment, Product Offerings)
Table 218. Biomin Holding GmbH Profile 2020 (CEO, HQ, Founded, Website)
Table 219. Biomin Holding GmbH Animal Vaccines Selected Recent Contracts 2017-2020 (Date, Program Type, Details)
Table 220. Biomin Holding GmbH Animal Vaccines Product Offering (Segment, Product Offerings)
Table 221. Bio-Vet Profile 2020 (CEO, HQ, Founded, Website)
Table 222. Bio-Vet Selected Recent Contracts 2015-2020 (Date, Program Type, Details)
Table 223. Bio-Vet Animal Vaccines Product Offering (Segment, Product Offerings)
Table 224. Ceva Santé Animale Profile 2020 (CEO, HQ, Founded, Website)
Table 225. Ceva Santé Animale Animal Vaccines Product Offering (Segment, Product Offerings)
Table 226. Boehringer Ingelheim Profile 2020 (CEO, HQ, Founded, Website)
Table 227. Boehringer Ingelheim Animal Vaccines Selected Recent Contracts 2015-2020 (Date, Program Type, Details)
Table 228. Boehringer Ingelheim Animal Vaccines Product Offering (Segment, Product Offerings)
Table 229. Merck & Co., Inc. Profile 2020 (CEO, HQ, Founded, Website)
Table 230. Merck & Co., Inc. Animal Vaccines Product Offering (Segment, Product Offerings)
Table 231. Virbac Profile 2020 (CEO, HQ, Founded, Website)
Table 232. Virbac Animal Vaccines Product Offering (Segment, Product Offerings)
Table 233. Zoetis Profile 2020 (CEO, HQ, Founded, Website)
Table 234. Zoetis Animal Vaccines Product Offering (Segment, Product Offerings)
Table 235. Bimeda Holdings PLC Profile 2020 (CEO, Total Company Sales US$M, HQ, Founded, No. of Employees, Ticker, Website)
Table 236. Bimeda Holdings PLC Total Company Sales 2015-2019 (US$M, AGR %)
Table 237. Bimeda Holdings PLC Product Offering (Segment, Product Offerings)
Table 238. Other Companies Involved in the Animal Vaccines Market (Company, Location)
LIST OF FIGURES
Figure 1. Animal Vaccines Market Overview
Figure 2. Animal Vaccines Market Product Overview
Figure 3. Animal Vaccines Market Type Overview
Figure 4. Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 5. Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 6. Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 7. Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 8. Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 9. Animal Vaccines Submarket Forecast By Product 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 10. Animal Vaccines Submarket Forecast By Product 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 11. Animal Vaccines Submarket Forecast By Product 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 12. Animal Vaccines Submarket Forecast By Product 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 13. Animal Vaccines Submarket Forecast By Product 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 14. Live attenuated vaccine Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 15. Live attenuated vaccine Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID – Scenario V)
Figure 16. Live attenuated vaccine Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario U)
Figure 17. Live attenuated vaccine Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 18. Live attenuated vaccine Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 19. Livestock vaccine Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 20. Livestock vaccine Submarket Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID – Scenario V)
Figure 21. Livestock vaccine Submarket Forecast 2021-2031(US$M, Global AGR %) (COVID – Scenario U)
Figure 22. Livestock vaccine Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario W)
Figure 23. Livestock vaccine Submarket Forecast 2021-2031 (US$M, Global AGR %) (COVID – Scenario L)
Figure 24. Regional Animal Vaccines Market Forecast 2021-2031 (Sales US$M, Global AGR %)
Figure 25. Regional Animal Vaccines Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario V)
Figure 26. Regional Animal Vaccines Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario U)
Figure 27. Regional Animal Vaccines Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario W)
Figure 28. Regional Animal Vaccines Market Forecast 2021-2031 (Sales US$M, Global AGR %) (COVID - Scenario L)
Figure 29. North America Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %) (Before COVID)
Figure 30. North America Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 31. North America Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 32. North America Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 33. North America Animal Vaccines Market Forecast by Product 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 34. North America Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %)
Figure 35. North America Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 36. North America Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 37. North America Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 38. North America Animal Vaccines Market Forecast by Type 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 39. North America Animal Vaccines Market Forecast by Country 2021-2031 (US$M, AGR %) (Before COVID)
Figure 40. North America Animal Vaccines Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 41. North America Animal Vaccines Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 42. North America Animal Vaccines Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 43. North America Animal Vaccines Market Forecast by Country 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 44. US Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 45. US Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 46. US Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 47. US Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 48. US Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 49. Canada Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %)
Figure 50. Canada Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 51. Canada Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 52. Canada Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 53. Canada Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 54. Europe Animal Vaccines Market Forecast by Product 2021-2031 (US$M)
Figure 55. Europe Animal Vaccines Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario V)
Figure 56. Europe Animal Vaccines Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario U)
Figure 57. Europe Animal Vaccines Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario W)
Figure 58. Europe Animal Vaccines Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario L)
Figure 59. Europe Animal Vaccines Market Forecast by Type 2021-2031 (US$M) (Before COVID)
Figure 60. Europe Animal Vaccines Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 61. Europe Animal Vaccines Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 62. Europe Animal Vaccines Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 63. Europe Animal Vaccines Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 64. Europe Animal Vaccines Market Forecast by Country 2021-2031 (US$M, Global AGR %) (Before COVID)
Figure 65. Europe Animal Vaccines Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 66. Europe Animal Vaccines Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 67. Europe Animal Vaccines Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 68. Europe Animal Vaccines Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 69. UK Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 70. UK Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 71. UK Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID – Scenario U)
Figure 72. UK Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 73. UK Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 74. Germany Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %)
Figure 75. Germany Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 76. Germany Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 77. Germany Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 78. Germany Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 79. France Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %)
Figure 80. France Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 81. France Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 82. France Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 83. France Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 84. Rest of Europe Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 85. Rest of Europe Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 86. Rest of Europe Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 87. Rest of Europe Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 88. Rest of Europe Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 89. Asia-Pacific Animal Vaccines Market Forecast by Product 2021-2031 (US$M) (Before COVID)
Figure 90. Asia-Pacific Animal Vaccines Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario V)
Figure 91. Asia-Pacific Animal Vaccines Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario U)
Figure 92. Asia-Pacific Animal Vaccines Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario W)
Figure 93. Asia-Pacific Animal Vaccines Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario L)
Figure 94. Asia-Pacific Animal Vaccines Market Forecast by Type 2021-2031 (US$M)
Figure 95. Asia-Pacific Animal Vaccines Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 96. Asia-Pacific Animal Vaccines Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 97. Asia-Pacific Animal Vaccines Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 98. Asia-Pacific Animal Vaccines Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 99. Asia-Pacific Animal Vaccines Market Forecast by Country 2021-2031 (US$M, AGR %) (Before COVID)
Figure 100. Asia-Pacific Animal Vaccines Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario V)
Figure 101. Asia-Pacific Animal Vaccines Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario U)
Figure 102. Asia-Pacific Animal Vaccines Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario W)
Figure 103. Asia-Pacific Animal Vaccines Market Forecast by Country 2021-2031 (US$M, Global AGR %) (COVID - Scenario L)
Figure 105. China Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %)
Figure 106. China Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 107. China Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 108 China Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 109. China Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 110. India Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %)
Figure 111. India Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 112. India Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 113. India Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 114. India Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 115. Japan Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 116. Japan Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 117. Japan Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 118. Japan Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 119. Japan Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 120. Rest of APAC Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 121. Rest of APAC Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 122. Rest of APAC Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 123. Rest of APAC Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 124. Rest of APAC Animal Vaccines Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 125. Middle East & Africa Animal Vaccines Market Forecast by Product 2021-2031 (US$M)
Figure 126. Middle East & Africa Animal Vaccines Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario V)
Figure 127. Middle East & Africa Animal Vaccines Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario U)
Figure 128. Middle East & Africa Animal Vaccines Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario W)
Figure 129. Middle East & Africa Animal Vaccines Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario L)
Figure 130. Middle East & Africa Animal Vaccines Market Forecast by Type 2021-2031 (US$M)
Figure 131. Middle East & Africa Animal Vaccines Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 132. Middle East & Africa Animal Vaccines Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 133. Middle East & Africa Animal Vaccines Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 134. Middle East & Africa Animal Vaccines Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 135. Latin America Animal Vaccines Market Forecast by Product 2021-2031 (US$M)
Figure 136. Latin America Animal Vaccines Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario V)
Figure 137. Latin America Animal Vaccines Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario U)
Figure 138. Latin America Animal Vaccines Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario W)
Figure 139. Latin America Animal Vaccines Market Forecast by Product 2021-2031 (US$M) (COVID - Scenario L)
Figure 140. Latin America Animal Vaccines Market Forecast by Type 2021-2031 (US$M)
Figure 141. Latin America Animal Vaccines Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario V)
Figure 142. Latin America Animal Vaccines Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario U)
Figure 143. Latin America Animal Vaccines Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario W)
Figure 144. Latin America Animal Vaccines Market Forecast by Type 2021-2031 (US$M) (COVID - Scenario L)
Figure 145. Brazil Animal Vaccines Market Forecast 2021-2031 (US$M)
Figure 146. Brazil Animal Vaccines Market Forecast 2021-2031 (US$M) (COVID - Scenario V)
Figure 147. Brazil Animal Vaccines Market Forecast 2021-2031 (US$M) (COVID - Scenario U)
Figure 148. Brazil Animal Vaccines Market Forecast 2021-2031 (COVID - Scenario W)
Figure 149. Brazil Animal Vaccines Market Forecast 2021-2031 (COVID - Scenario L)
Figure 150. Mexico Animal Vaccines Market Forecast 2021-2031 (US$M) (Before COVID)
Figure 151. Mexico Animal Vaccines Market Forecast 2021-2031 (US$M) (COVID - Scenario V)
Figure 152. Mexico Animal Vaccines Market Forecast 2021-2031 (US$M) (COVID - Scenario U)
Figure 153. Mexico Animal Vaccines Market Forecast 2021-2031 (US$M) (COVID - Scenario W)
Figure 154. Mexico Animal Vaccines Market Forecast 2021-2031 (US$M) (COVID - Scenario L)
Figure 155. Rest of Latin America Animal Vaccines Market Forecast 2021-2031 (US$M) (Before COVID)
Figure 156. Rest of Latin America Animal Vaccines Market Forecast 2021-2031 (US$M) (COVID - Scenario V)
Figure 157. Rest of Latin America Animal Vaccines Market Forecast 2021-2031 (US$M) (COVID - Scenario U)
Figure 158. Rest of Latin America Animal Vaccines Market Forecast 2021-2031 (US$M) (COVID - Scenario W)
Figure 159. Rest of Latin America Animal Vaccines Market Forecast 2021-2031 (US$M) (COVID - Scenario L)
Figure 160. Porter’s Five Force Analysis
Companies Mentioned
1. Bayer AG
2. Heska Corporation
3. Merck Animal Health
4. Boehringer Ingelheim GmbH
5. Sanofi
6. BioVet KZ
7. Zoetis Inc.,
8. Bimeda Holdings Plc
9. Vaxxinova GmbH-Germany
10. Romvac company S.A.
11. Hygieia Biological Laboratories
12. IDEXX Laboratories, Inc
13. Veterinary Diagnostic Technology, Inc.
14. Veterinary Allergy Reference Laboratory
15. Vetazyme Corporation
16. The Vaccine Company
17. T-Cyte Therapeutics, Inc.
18. Pfizer Animal Health
19. Indian Immunologicals Ltd
20. Novartis Vaccines & Diagnostics, Inc.
21. Lohmann Animal Health International
22. GE Healthcare
23. Charles River Laboratories, Inc.
24. MSD Animal Health
25. Bovicure Pharma Private Limited
26. Bupo Animal Health (SA)
27. Chr. Hansen Holdings A/S
28. Danisco A/S DuPont
29. Dechra Pharmaceuticals Plc
30. ECO animal health
31. Animal Medics
32. Ashish Life Science Pvt Limited (ALS)
33. Hatvet Pharma Private Limited
34. Lillidale Animal Health
35. Lutim Pharma Pvt. Ltd.
36. Arab Pesticides and Veterinary Drugs Mfg. Co (Mobedco)
37. Neogen Corporation
38. Norbrook Laboratories Limited
39. Novus International Inc.
40. Orion Corporation
41. PetIQ, LLC
42. Phibro Animal Health
43. SmartVet Holdings Inc.
44. The Alltech Group
45. UCBVET
46. Vetoquinol S.A.
47. Vitafor NV
48. Zydus animal health Limited
49. Abbott Laboratories
50. Bioniche Animal Health, Inc.
Companies Profiled in the Report
1. Bayer AG
2. Heska Corporation
3. Merck Animal Health
4. Boehringer Ingelheim GmbH
5. Sanofi
6. BioVet KZ
7. Zoetis Inc.,
8. Bimeda Holdings PLC
9. Vaxxinova GmbH
10. Romvac company S.A.
11. Hygieia Biological Laboratories
12. IDEXX Laboratories, Inc
List of Companies Mentioned in the Report
1. Bayer AG
2. Heska Corporation
3. Merck Animal Health
4. Boehringer Ingelheim GmbH
5. Sanofi
6. BioVetKZ
7. Zoetis Inc.,
8. Bimeda Holdings PLC
9. Vaxxinova GmbH
10. Romvac company S.A.
11. Hygieia Biological Laboratories
12. IDEXX Laboratories, Inc
13. Veterinary Diagnostic Technology, Inc.
14. Veterinary Allergy Reference Laboratory
15. Vetazyme Corporation
16. The Vaccine Company
17. T-Cyte Therapeutics, Inc.
18. Pfizer Animal Health
19. Indian Immunologicals Limited
20. Novartis Vaccines & Diagnostics, Inc.
21. Lohmann Animal Health International
22. GE Healthcare
23. Charles River Laboratories, Inc.
24. MSD Animal Health
25. Bovicure Pharma Private Limited
26. Bupo Animal Health (SA)
27. Chr. Hansen Holdings A/S
28. Danisco A/S DuPont
29. Dechra Pharmaceuticals Plc
30. ECO animal health
31. Animal Medics
32. Ashish Life Science Pvt Limited (ALS)
33. Hatvet Pharma Private Limited
34. Lillidale Animal Health
35. Lutim Pharma Pvt. Ltd.
36. Arab Pesticides and Veterinary Drugs Mfg.Co (Mobedco)
37. Neogen Corporation
38. Norbrook Laboratories Limited
39. Novus International Inc.
40. Orion Corporation
41. PetIQ, LLC
42. Phibro Animal Health
43. SmartVet Holdings Inc.
44. The Alltech Group
45. UCBVET
46. Vetoquinol S.A.
47. Vitafor NV
48. Zydus animal health Limited
49. Abbott Laboratories
50. Bioniche Animal Health, Inc.
List of Organizations Mentioned in the Report
1. Companion Animal Parasite Council (CAPC)
2. Parasitic Zoonoses & World Health Organization.
3. Health for Animals
4. Institute of Food science and technology (IFST)
5. American Veterinary Medical Association
6. United States Department of Agriculture
7. US Food & Drug Administration
8. Meat & Diary production
9. US National Library of Medicine
10. National Institutes of Health
11. National Association for Biomedical Research
12. Center for Disease Control and Prevention (CDC)
13. NIH’s National Institute of Child Health and Human Development
14. Canadian Veterinary Medical Association (CVMA)
15. National Office of Animal Health (NOAH)
16. US Centers for Disease Control and Prevention
17. National Institute of Food and Agriculture (NIFA)
18. World Small Animal Veterinary Association Vaccination
19. National Animal Welfare Organizations
20. The American Pet Product Association
21. The Food & Agriculture Organisation
1. Bayer AG
2. Heska Corporation
3. Merck Animal Health
4. Boehringer Ingelheim GmbH
5. Sanofi
6. BioVet KZ
7. Zoetis Inc.,
8. Bimeda Holdings PLC
9. Vaxxinova GmbH
10. Romvac company S.A.
11. Hygieia Biological Laboratories
12. IDEXX Laboratories, Inc
List of Companies Mentioned in the Report
1. Bayer AG
2. Heska Corporation
3. Merck Animal Health
4. Boehringer Ingelheim GmbH
5. Sanofi
6. BioVetKZ
7. Zoetis Inc.,
8. Bimeda Holdings PLC
9. Vaxxinova GmbH
10. Romvac company S.A.
11. Hygieia Biological Laboratories
12. IDEXX Laboratories, Inc
13. Veterinary Diagnostic Technology, Inc.
14. Veterinary Allergy Reference Laboratory
15. Vetazyme Corporation
16. The Vaccine Company
17. T-Cyte Therapeutics, Inc.
18. Pfizer Animal Health
19. Indian Immunologicals Limited
20. Novartis Vaccines & Diagnostics, Inc.
21. Lohmann Animal Health International
22. GE Healthcare
23. Charles River Laboratories, Inc.
24. MSD Animal Health
25. Bovicure Pharma Private Limited
26. Bupo Animal Health (SA)
27. Chr. Hansen Holdings A/S
28. Danisco A/S DuPont
29. Dechra Pharmaceuticals Plc
30. ECO animal health
31. Animal Medics
32. Ashish Life Science Pvt Limited (ALS)
33. Hatvet Pharma Private Limited
34. Lillidale Animal Health
35. Lutim Pharma Pvt. Ltd.
36. Arab Pesticides and Veterinary Drugs Mfg.Co (Mobedco)
37. Neogen Corporation
38. Norbrook Laboratories Limited
39. Novus International Inc.
40. Orion Corporation
41. PetIQ, LLC
42. Phibro Animal Health
43. SmartVet Holdings Inc.
44. The Alltech Group
45. UCBVET
46. Vetoquinol S.A.
47. Vitafor NV
48. Zydus animal health Limited
49. Abbott Laboratories
50. Bioniche Animal Health, Inc.
List of Organizations Mentioned in the Report
1. Companion Animal Parasite Council (CAPC)
2. Parasitic Zoonoses & World Health Organization.
3. Health for Animals
4. Institute of Food science and technology (IFST)
5. American Veterinary Medical Association
6. United States Department of Agriculture
7. US Food & Drug Administration
8. Meat & Diary production
9. US National Library of Medicine
10. National Institutes of Health
11. National Association for Biomedical Research
12. Center for Disease Control and Prevention (CDC)
13. NIH’s National Institute of Child Health and Human Development
14. Canadian Veterinary Medical Association (CVMA)
15. National Office of Animal Health (NOAH)
16. US Centers for Disease Control and Prevention
17. National Institute of Food and Agriculture (NIFA)
18. World Small Animal Veterinary Association Vaccination
19. National Animal Welfare Organizations
20. The American Pet Product Association
21. The Food & Agriculture Organisation
Download sample pages
Complete the form below to download your free sample pages for Animal Vaccine Market Report to 2031Related reports
Animal Parasiticides Market Report to 2031
Where is the Global Animal Parasiticides market heading? If you are involved in this sector you must read this newly...Full DetailsPublished: 01 January 1970Adult Vaccines Market Report to 2031
The adult vaccines market is expected to attain a significant growth rate due to the increasing incidence of infectious viruses...Full DetailsPublished: 01 January 1970Vaccines Sales Market Report 2020-2030
Visiongain forecasts a continuing growth in global market, submarket and product sales as human vaccines drive pharmaceutical business sales. New...
Full DetailsPublished: 10 September 2020Vaccine Delivery Devices Market Report 2021-2031
Growing demand for cost-effective drugs; rising prevalence of chronic diseases; mounting investment in drug R&D by biopharmaceutical companies; new product...Full DetailsPublished: 06 January 2021Companion Animal Diagnostics Market Report 2021-2031
All regions are facing rapid growth in the companion animal population. Companion animal are at high risk of developing various...Full DetailsPublished: 01 January 1970Pet Care E-Commerce Market Report 2020-2030
The increase in the number of pets globally and increasing the purchasing power of the pet owners are increasing the...
Full DetailsPublished: 01 January 1970Veterinary Therapeutics Market Report 2021-2031
Where the Veterinary Therapeutics is market heading? If you are involved in this sector you must read this newly updated...Full DetailsPublished: 01 January 1970Veterinary Chemistry Analyzer Market Forecast 2020-2030
As clinic blood samples are used, health and safety rules require universal precautions to be observed during the treatment of...Full DetailsPublished: 01 January 1970Veterinary Vaccines Market Report 2022-2032
The increased frequency of zoonotic illnesses, activities by different government agencies and animal groups to protect animal health, and the...Full DetailsPublished: 28 February 2022Meningococcal Vaccines Market Report 2021-2031
Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations is...Full DetailsPublished: 30 September 2021
Download sample pages
Complete the form below to download your free sample pages for Animal Vaccine Market Report to 2031Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Sara Peerun stating your chosen report title to sara.peerun@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Vaccine Contract Manufacturing Market Report 2023-2033
The global Vaccine Contract Manufacturing Market is projected to grow at a CAGR of 13.2% by 2033
24 May 2023
Visiongain Publishes Cell & Gene Therapy Cold Chain Logistics Market Report 2023-2033
The global Cell & Gene Therapy Cold Chain Logistics market is projected to grow at a CAGR of 15% by 2033
23 May 2023
Visiongain Publishes Single-use Bioprocessing Probes & Sensors Market Report 2023-2033
The global Single-Use Bioprocessing Probes & Sensors market was valued US$2,493.8 million in 2022 and is projected to grow at a CAGR of 15.2% during the forecast period 2023-2033.
22 May 2023
Visiongain Publishes Dental Consumables Market Report 2023-2033
The global Dental Consumables market is valued at US$21,759.4 million in 2023 and is expected to register a CAGR of 8% from 2023 to 2033.
22 May 2023
